The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 19, 2018

Filed:

Jan. 08, 2015
Applicant:

Nordic Bioscience A/s, Herlev, DK;

Inventors:

Jacob Hull Kristensen, Soborg, DK;

Diana Julie Oersnes-Leeming, Espergaerde, DK;

Morten Karsdal, Kobenhavn O, DK;

Assignee:

Nordic Bioscience A/S, Herlev, DK;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/53 (2006.01); G01N 33/68 (2006.01); C07K 16/18 (2006.01); C07K 16/40 (2006.01); G01N 33/577 (2006.01);
U.S. Cl.
CPC ...
G01N 33/6878 (2013.01); C07K 16/18 (2013.01); C07K 16/40 (2013.01); G01N 33/577 (2013.01); G01N 33/6893 (2013.01); C07K 2317/33 (2013.01); C07K 2317/34 (2013.01); G01N 2333/78 (2013.01); G01N 2333/96411 (2013.01); G01N 2333/96419 (2013.01); G01N 2800/122 (2013.01); G01N 2800/7052 (2013.01);
Abstract

Provided is a method of bioassay for the quantification of peptide fragments elevated in lung diseases such as COPD, SCC, or IPF. The peptide fragments comprise a neo-epitope formed at a cleavage site by cleavage in vivo of elastin by a proteinase. In the method a sample is contacted with an antibody having specific binding affinity for the neo-epitope amino acid sequence and determining the level of binding is determined where the antibody binds one of the following terminal sequences: . . . FGPGVV, . . . VPGLGV or IKAPKL . . . . Also provided are antibodies and immunoassay kits for use in such methods.


Find Patent Forward Citations

Loading…